Inicio>>Signaling Pathways>> Endocrinology and Hormones>> Opioid Receptor>>LY2444296

LY2444296 (Synonyms: FP3FBZ)

Catalog No.GC39193

LY2444296 es un antagonista del receptor opioide kappa (KOPR) biodisponible por vÍa oral, de alta afinidad y selectivo de acciÓn corta, con un valor Ki de ~1 nM.

Products are for research use only. Not for human use. We do not sell to patients.

LY2444296 Chemical Structure

Cas No.: 1346133-11-6

Tamaño Precio Disponibilidad Cantidad
5mg
74,00 $
Disponible
10mg
139,00 $
Disponible
50mg
556,00 $
Disponible
100mg
1.020,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

LY2444296 is an orally bioavailable, high-affinity and selective short-acting kappa opioid receptor (KOPR) antagonist, with a Ki value of ∼1 nM. LY2444296 exhibits anti-anxiety like effects[1][2].

[1]. Huang P, et al. Two short-acting kappa opioid receptor antagonists (zyklophin and LY2444296) exhibited different behavioral effects from the long-acting antagonist norbinaltorphimine in mouse anxiety tests. Neurosci Lett. 2016 Feb 26;615:15-20. [2]. Valenza M, et al. "Effects of the novel relatively short-acting kappa opioid receptor antagonist LY2444296 in behaviors observed after chronic extended-access cocaine self-administration in rats". Psychopharmacology (Berl). 2017 Aug;234(15):2219-2231.

Reseñas

Review for LY2444296

Average Rating: 5 ★★★★★ (Based on Reviews and 36 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for LY2444296

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.